Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotrastaurin vs Cyclosporine in Renal Transplant Extension
NCT00820911Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2008
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of sotrastaurin in kidney transplant rejection, sponsored by Novartis. Started Sep 2008; status: completed.
02
Drugs
sotrastaurin
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00820911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00820911.